What is the main business of Invimed - T?

The main business activity of Invimed - T focuses on dispensing chemist in specialised stores.

When was the company founded?

The company was registered in the Polish National Court Register (KRS) on June 25, 2001.

Where is the headquarters located?

The headquarters is located at: Rakowiecka 36, 02-532 Warszawa.

Who is on the management board?

The management board includes: Wojciech Maurycy Łukasiewicz (Member of the Management Board) and Piotr Wojciechowski (Member of the Management Board).

What is the share capital?

The share capital of the company is PLN 1,582,100 (approx. $427,364).

What period do the latest financial data cover?

The latest available financial statement covers the period from January 1, 2024 to December 31, 2024.

What was the revenue?

In 2024, the company generated total revenue of $22,727,442, representing an increase of 19.0% compared to 2023.

Is the company profitable?

Yes, in 2024 the company was profitable, achieving a net profit of $230,458.

What is the largest operating cost?

The largest operating cost category falls under cost of goods and materials sold. This category amounted to $16,575,539 in 2024, representing 76% of all operating expenses.

Invimed - Tsp. z o.o.

Dispensing chemist in specialised stores

KRS: NIP: REGON:

Overview

Status

Active

Registry date

2001-06-25

Share capital

1,582,100.00 PLN

Activity description

Invimed - T operates fertility and IVF clinics in Warsaw, Gdynia, Katowice, Poznań and Wrocław. Its services include fertility diagnostics for women and men, genetic and semen testing, and fertility preservation. Treatment options include insemination, IVF and egg donation.

Registered address

Rakowiecka 36, 02-532 Warszawa, Poland

Website

invimed.pl

Phone

Social media

Electronic delivery address

AE:PL-59674-21073-ASIVV-20

Financials

Revenue history (in m)

Financial insight

Possible Estonian CIT: Equity includes Art. 28d line items, but all amounts are 0 – this may be an accounting template or the first year of the regime.

Filing timeliness

3 of 6 financial statements were filed late (the longest delay 59 days for 2021). All were audited by a statutory auditor.

202508/07/2026
202416/07/2025
202330/07/2024
202207/07/2023
202112/09/2022
202025/09/2021

Filed on timeDelayFiling deadline

Data and insights are generated automatically from financial statements – they may contain errors and are neither a credit assessment nor business advice.

Statistics

How the company ranks by revenue within its industry, region and across Poland in 2025.

Results vs industry

Revenue

This companyUSD 22.87mMedianUSD 1.92mAverageUSD 5.20m

Net profit

This companyUSD 232.87kMedianUSD 20.66kAverageUSD 86.55k

Operating costs

This companyUSD 22.25mMedianUSD 1.88mAverageUSD 5.04m

Assets

This companyUSD 5.22mMedianUSD 544.32kAverageUSD 1.76m

News

2026-10-01

First visit for 1 PLN

2026-06-24

"Give Yourself Peace" – Relaxation with Yoga at Invimed Katowice Clinic

2026-03-16

Non-invasive prenatal tests available at Invimed

2026-02-19

Invimed Katowice will run in the 13th Silesian Angels Run!

2026-01-29

Yoga in Warsaw – Invimed Praga

2025-11-20

We Celebrate Success! Dr Beata Makowska – Gynecologist of the Year 2025

Industry

Offer

Infertility treatment
In vitro fertilisation
Infertility diagnostics
Genetic testing
Fertility preservation
Egg freezing
Sperm freezing

Website technology

Website

WordPress

Analytics and marketing

Google Tag Manager

Public procurement

Invimed - T is the contractor in 55 public sector contracts, worth USD 2.32k in total. They were signed with 2 public buyers. The largest number (51) were signed with Dom Dziecka Nr 1 Nasz Dom Im. Maryny Falskiej.

Signed on	Subject	Amount	Public buyer
Sep 26, 2026	Expense relates to the purchase of medicines for a beneficiary	$9.98	Dom Dziecka Nr 1 Nasz Dom Im. Maryny Falskiej
Sep 25, 2026	Expense relates to the purchase of medicines for a beneficiary	$68.53	Dom Dziecka Nr 1 Nasz Dom Im. Maryny Falskiej
Sep 24, 2026	Expense relates to the purchase of medicines for a beneficiary	$28.30	Dom Dziecka Nr 1 Nasz Dom Im. Maryny Falskiej

National Health Fund (NFZ) contracts

Invimed - T has been an NFZ healthcare provider since 2023. In 2026 it is performing 15 contracts with a total value of USD 2.05k. All its contracts were worth USD 11.51k in total.

NFZ contract value by year (USD)

Type of care	NFZ branch	Contracts	Value in 2026
Pilot programmes	dolnośląskie	3	USD 1.05k
Pilot programmes	mazowieckie	3	USD 567.26
Pilot programmes	pomorskie	1	USD 324.15
Pilot programmes	wielkopolskie	1	USD 81.04
Pilot programmes	małopolskie	1	USD 27.01

Trademarks

Invimed - T holds 1 active trademark registered with the Polish Patent Office. The first mark was filed in 2018.

Mark	Number	Classes	Status	Protected until
TWÓJ FARMACEUTA	Z.485708	35, 41	Protected	May 8, 2028

Mark	Protected until
TWÓJ FARMACEUTA	May 8, 2028

Authorized Representatives

Magdalena Lipczyńska – Management Board Member

Wojciech Maurycy Łukasiewicz – Management Board Member

Piotr Wojciechowski – Management Board Member

Manner of representation

In the case of a multi-member management board, joint action by two members of the management board or by one member of the management board jointly with a commercial proxy is required.

Ownership

Owner	Shares	Share value	Stake
Abc Medicover Holdings B.v.	31,642	$427,363.59	100%

Beneficial owners

Person	Rights

Bank accounts

Registered as a VAT taxpayer on 2007-03-01.

ING Bank Śląski
61 1050 0086 1000 0090 3009 8967
ING Bank Śląski
18 1050 0086 1000 0090 3011 2933
ING Bank Śląski
40 1050 0086 1000 0090 3011 2925

Debt

No entries in the National Debtors Register (KRZ).

MSiG notices

Publication date	Event
Aug 5, 2014	Merger plan
Aug 5, 2014	Merger plan
Jul 5, 2012	Merger plan

Public aid

Grant date	Purpose	Gross amount	Granting body
Jun 8, 2026	De minimis aid (in accordance with Commission Regulation 2023/2831)	$2,611$2,611	Krajowa

Regulatory authorisations

Authority	Type	Status
BDO	BDO register entry	Active

Competitors

	Name	Revenue	Website
	Farm-Med Przemysław Czubińskisp. j.	$2,942,348.53	farm-med.pl

Change history

Date	Event
2026-04-28	PKD change (Removed: 4 codes; Added: 4 codes)
2023-09-29	Share capital increase (1,082,100.00 PLN → 1,582,100.00 PLN)
2019-04-01	Share capital reduction (3,961,000.00 PLN → 1,082,100.00 PLN)
2014-10-31	Share capital increase (3,960,000.00 PLN → 3,961,000.00 PLN)
2012-12-31	Address change (Al. Jerozolimskie 96, 00-807, Warszawa → Rakowiecka 36, 02-532, Warszawa)

FAQ

Last updated: 2026-10-07